Literature DB >> 9355956

Pilot study of transurethral needle ablation (TUNA) in treatment of nonbacterial prostatitis.

P H Chiang1, E M Tsai, C P Chiang.   

Abstract

Transurethral needle ablation (TUNA) was performed on seven patients with chronic nonbacterial prostatitis who failed to respond to conventional treatments administered for more than half a year. The TUNA procedure heated the prostate to a temperature ranging from 90 degrees to 100 degrees C while the urethral temperature was maintained below 43 degrees C by a protective sheath and irrigation. After treatment, four patients showed complete resolution of symptoms and three a partial improvement. All patients had a decrease in the leukocyte count in expressed prostatic secretions (EPS) 1 month after treatment. Recurrence of abnormal inflammatory cells in the EPS was noted in two patients at 3 months after treatment. The subjective improvement has been maintained during the subsequent follow-up. From these results, TUNA is considered to be an effective, safe, and easy treatment for most patients with nonbacterial prostatitis.

Entities:  

Mesh:

Year:  1997        PMID: 9355956     DOI: 10.1089/end.1997.11.367

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

1.  Transurethral needle ablation and chronic nonbacterial prostatitis.

Authors:  Robert M Moldwin
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 3.092

Review 2.  The impact of chronic prostatitis/chronic pelvic pain syndrome on patients.

Authors:  Mary McNaughton Collins
Journal:  World J Urol       Date:  2003-04-02       Impact factor: 4.226

Review 3.  Minimally invasive therapies for prostatitis.

Authors:  Peter Zvara; Jeffrey B Folsom; Mark K Plante
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

Review 4.  Advanced therapy for prostatitis: minimally invasive and invasive therapies.

Authors:  Assaad El-Hakim; Darshan K Shah; Arthur D Smith
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.